Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May-Jun;37(3):900-909.
doi: 10.1111/jvim.16702. Epub 2023 Apr 15.

N-terminal brain natriuretic peptide, cardiac troponin-I, and point-of-care ultrasound in dogs with cardiac and noncardiac causes of nonhemorrhagic ascites

Affiliations

N-terminal brain natriuretic peptide, cardiac troponin-I, and point-of-care ultrasound in dogs with cardiac and noncardiac causes of nonhemorrhagic ascites

Alice G N Morey et al. J Vet Intern Med. 2023 May-Jun.

Abstract

Background: Nonhemorrhagic ascites (NHA) can be caused by cardiac diseases (cNHA) and noncardiac diseases (ncNHA). N-terminal brain natriuretic peptide (NT-proBNP), cardiac troponin-I (cTnI), and point-of-care ultrasound (POCUS) may differentiate between cNHA and ncNHA.

Hypothesis/objectives: We compared NT-proBNP and cTnI concentrations as well as POCUS findings in dogs presented with cNHA and ncNHA.

Animals: Dogs (n = 60) were enrolled based on identification of NHA with an effusion packed cell volume < 10%.

Methods: Blood samples were collected and POCUS was performed on all dogs. Dogs were diagnosed with cNHA (n = 28) or ncNHA (n = 32) based on echocardiography. The cNHA group was subdivided into cardiac non-pericardial disease (n = 17) and pericardial disease (n = 11).

Results: The NT-proBNP concentration (median; range pmol/L) was significantly higher in the cNHA group (4510; 250-10 000) compared to the ncNHA group (739.5; 250-10 000; P = .01), with a sensitivity of 53.8% and specificity of 85.7% using a cut-off of 4092 pmol/L. The NT-proBNP concentrations were significantly higher in the cardiac non-pericardial disease group (8339; 282-10 000) compared with the pericardial disease group (692.5; 250-4928; P = .002). A significant difference in cTnI concentration (median; range ng/L) between the cNHA group (300; 23-112 612) and ncNHA group (181; 17-37 549) was not detected (P = .41). A significantly higher number of dogs had hepatic venous and caudal vena cava distension in the cNHA group compared to the ncNHA group, respectively (18/28 vs 3/29, P < .0001 and 13/27 vs 2/29, P < .001). Gall bladder wall edema was not significantly different between groups (4/28 vs 3/29, P = .74).

Conclusions and clinical importance: NT-proBNP concentration and POCUS help distinguish between cNHA and ncNHA.

Keywords: BNP; canine; congestive heart failure; echocardiography.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow chart showing the number of dogs enrolled into each group after identification of nonhemorrhagic ascites (PCV < 10%).
FIGURE 2
FIGURE 2
Flow chart showing the number of dogs that had physical examination, point‐of‐care ultrasound (POCUS), and cardiac biomarker results analyzed throughout the study.
FIGURE 3
FIGURE 3
Box and whisker plot showing the plasma concentration of NT‐proBNP in dogs with cardiac (n = 26) and noncardiac causes (n = 28) of nonhemorrhagic ascites (P = .01). Center line shows the median value; box limits indicate the 25th and 75th percentiles, and the whiskers extend 1.5 times the interquartile range. Outliers are represented as dots and + sign represents the mean.
FIGURE 4
FIGURE 4
Box and whisker plot showing the plasma concentration of NT‐proBNP in dogs with cardiac non‐pericardial disease (n = 16) and noncardiac causes (n = 28) of nonhemorrhagic ascites (P < .001). Center line shows the median value; box limits indicate the 25th and 75th percentiles, and the whiskers extend 1.5 times the interquartile range. Outliers are represented as dots and + sign represents the mean.

Similar articles

References

    1. Walter J. Abdominal enlargement. In: Ettinger SJ, Feldman EC, Cote E, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. Vol 1. 8th ed. St. Louis, MO: Elsevier; 2017:78‐81.
    1. Valenciano AC, Rizzi TE. Abdominal, thoracic, and pericardial effusions. In: Valenciano AC, Cowell RL, eds. Cowell and Tyler's Diagnostic Cytology and Hematology of the Dog and Cat. 5th ed. St. Louis, MO: Elsevier; 2020:229‐246.
    1. Zoia A, Drigo M, Piek CJ, Simioni P, Caldin M. Hemostatic findings in ascitic fluid: a cross‐sectional study in 70 dogs. J Vet Intern Med. 2017;31(1):43‐50. - PMC - PubMed
    1. Kopcinovic LM, Culej J. Pleural, peritoneal and pericardial effusions – a biochemical approach. Biochem Med (Zagreb). 2014;24(1):123‐137. - PMC - PubMed
    1. Dempsey SM, Ewing PJ. A review of the pathophysiology, classification, and analysis of canine and feline cavitary effusions. J Am Anim Hosp Assoc. 2011;47(1):1‐11. - PubMed